These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 17825715)
1. Biomarkers in heart failure. Does prognostic utility translate to clinical futility? Maisel A J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715 [No Abstract] [Full Text] [Related]
2. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714 [TBL] [Abstract][Full Text] [Related]
3. [Natriuretic cardiac hormones. Clinical use in heart failure]. Nielsen SJ; Gøtze JP; Raymond IE; Grønning BA; Kirk V; Bay-Nielsen M; Hildebrandt PR; Aldershvile J Ugeskr Laeger; 2004 Jan; 166(4):248-53. PubMed ID: 14964102 [No Abstract] [Full Text] [Related]
4. Are multiple biomarker testing strategies ready for prime time in heart failure? Lee DS; Tu JV Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366 [No Abstract] [Full Text] [Related]
8. [B-type natriuretic peptide as a prognostic marker in heart failure]. Yasumura Y Nihon Rinsho; 2007 May; 65 Suppl 5():300-3. PubMed ID: 17569316 [No Abstract] [Full Text] [Related]
9. Prospects for using a blood sample in the diagnosis of heart failure. Struthers AD QJM; 1995 May; 88(5):303-6. PubMed ID: 7796082 [No Abstract] [Full Text] [Related]
11. The role of b-type natriuretic peptide in heart failure management. Newton PJ; Betihavas V; Macdonald P Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure]. Souverijn JH Ned Tijdschr Geneeskd; 2008 Jan; 152(4):231; author reply 231. PubMed ID: 18320951 [No Abstract] [Full Text] [Related]
13. BNP for clinical monitoring of heart failure. Troughton RW; Richards AM Heart Fail Clin; 2006 Jul; 2(3):333-43. PubMed ID: 17386902 [No Abstract] [Full Text] [Related]
14. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related]
15. Diagnosing acute heart failure: the mathematician and the clinician. Dickstein K J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123 [No Abstract] [Full Text] [Related]
16. B-type natriuretic peptides: applications for heart failure management in 2005. Troughton RW; Richards M Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104 [No Abstract] [Full Text] [Related]
17. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526 [TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)? Arora V; Bhandari S Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049 [No Abstract] [Full Text] [Related]